跳至主要内容
临床试验/CTRI/2012/09/003012
CTRI/2012/09/003012已完成未知

A Study to derive normative distribution of CIMT and to determine its cOrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population. - SCORE India

AstraZeneca Pharma India Ltd0 个研究点目标入组 1,500 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Provision of subject informed consent
  • Female or male aged 30 years and over

排除标准

  • 1.Subjects with established cardiovascular event
  • 2.History of acute or chronic GI, renal, hepatic, CNS, respiratory, infectious, or psychiatric diseases that may affect the outcome of the study
  • 3.Intake of lipid lowering drug in the past 3 months
  • 4.Subjects with known hypersensitivity to carotid bulb
  • 5.Any medical condition that, in the opinion of the investigator, would interfere with safe completion of the study
  • 6.Pregnant or lactating women
  • 7.If participating in any clinical study, the subject cannot take part in this study

研究者

相似试验